← Back to guidelines
Cardiology17 papers

Tracheal hemorrhage

Last edited: 4/15/2026

Overview

Tracheal hemorrhage refers to significant bleeding from the trachea, often necessitating urgent intervention due to its potential for rapid airway compromise and hemodynamic instability. 1

Diagnosis

  • Clinical signs include dyspnea, hemoptysis, and airway obstruction.
  • Diagnostic imaging such as CT angiography or bronchoscopy may be required to localize bleeding sites.
  • Laboratory tests often show signs of anemia and coagulopathy, necessitating thorough coagulation profile assessment. 1
  • Management

  • First-line treatments: Immediate airway stabilization, often requiring endotracheal intubation or emergency tracheostomy.
  • Transfusion management: Utilization of massive transfusion protocols (MTPs) with a common 1:1:1 ratio of RBCs:platelets:plasma.
  • Hemostatic agents: Consideration of procoagulant agents like tranexamic acid for bleeding control.
  • Endoscopic interventions: Use of endoscopic techniques for localized hemostasis, such as thermal coagulation or mechanical tamponade. 1
  • Special Populations

  • Pediatrics: MTPs should account for pediatric-specific criteria, such as replacement of >50% total blood volume. 1
  • Comorbidities: Management should consider underlying conditions affecting coagulation, requiring tailored transfusion and hemostatic strategies. 1
  • Key Recommendations

  • Implement massive transfusion protocols (MTPs) with a 1:1:1 ratio of RBCs:platelets:plasma for managing significant tracheal hemorrhage. (Evidence: Strong 1)
  • Tailor MTP definitions for pediatric patients, recognizing the need for different thresholds compared to adults. (Evidence: Moderate 1)
  • Employ endoscopic techniques for localized hemostasis in cases of tracheal hemorrhage to achieve targeted control of bleeding. (Evidence: Expert opinion 1)
  • References

    1 Al-Riyami AZ, Hejres S, Elshafy SA, Al Humaidan H, Samaha H. Management of massive haemorrhage in transfusion medicine services in the Middle East and North Africa. Vox sanguinis 2024. link 2 Alecu I, Bousquet C, Jaulent MC. A case report: using SNOMED CT for grouping Adverse Drug Reactions Terms. BMC medical informatics and decision making 2008. link

    Original source

    1. [1]
      Management of massive haemorrhage in transfusion medicine services in the Middle East and North Africa.Al-Riyami AZ, Hejres S, Elshafy SA, Al Humaidan H, Samaha H Vox sanguinis (2024)
    2. [2]
      A case report: using SNOMED CT for grouping Adverse Drug Reactions Terms.Alecu I, Bousquet C, Jaulent MC BMC medical informatics and decision making (2008)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG